Product Name: Ciclesonide
Synonyms: (r)-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde 21-isobutyrate;(R)-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde 21-isobutyrate;Ciclesonide
CAS: 126544-47-6
MF: C32H44O7
MW: 540.69
HS Code 2937210000
Assay: 99% min.
Standard: BP/EP/USP
Package: 1 kg /tin or foil bag; 10kg/cardboard drum
Characteristic: White Solid
Usage: Ciclesonide is a new inhaled glucocorticoid asthma medicine, corticosteroids, similar pharmaceutical include beclomethasone dipropionate, budesonide, fluticasone propionate, the product to non-active form of administration, was the airway activation of endogenous esterase spot to reach the target organ of active ingredients into the lung; Once activated, it showed a high local anti-inflammatory activity.
Ciclesonide successfully developed by the pharmaceutical company Altana, January 2005, the first time in the UK market, currently in Germany, Ireland market for the treatment of adults of all levels of persistent severe asthma, day 1 drug, the dose of 160μg or 80μg. For face the risk of asthma attacks in patients with severe asthma, such as the condition can not be controlled and need strong anti-inflammatory drugs, the FDA is in the dose can be increased to 160μg.